Home » Topics » BioWorld Science

BioWorld Science
RSS

Bionomics enters MoU with EmpathBio to explore combination of BNC-210 and EMP-01 for PTSD

Feb. 19, 2021

GSK initiates phase III program with RSV vaccine candidate GSK-3844766A for older adults

Feb. 18, 2021

U.K. clearance for first-in-human study of Avacta's FAP-activated doxorubicin prodrug AVA-6000

Feb. 18, 2021

ABO-102 demonstrates evidence of clinical benefit in patients with MPS IIIA

Feb. 18, 2021

vTv initiates phase I study of PDE4 inhibitor HPP-737 for psoriasis

Feb. 18, 2021

SciSparc signs agreement for phase IIa trial of SCI-110 for Alzheimer agitation

Feb. 18, 2021

Study may yield ways to harness bacterial antibiotic production

Feb. 18, 2021

AbFero receives funding for development of SP-420 for Parkinson's disease

Feb. 18, 2021

First patient dosed in U.S. phase II/III COVID-19 outpatient study of RHB-107

Feb. 18, 2021

N-803 plus BCG shows promise for treating NMIBC

Feb. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...